These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16510595)

  • 21. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-alpha, interleukin-8, and monocyte chemoattractant protein-1 in human first-trimester trophoblasts: possible roles in angiogenesis and immune regulation.
    Chen SU; Chou CH; Chao KH; Lee H; Lin CW; Lu HF; Yang YS
    Endocrinology; 2010 Jan; 151(1):369-79. PubMed ID: 19906815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
    Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
    J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation.
    Snider AJ; Zhang Z; Xie Y; Meier KE
    Am J Physiol Cell Physiol; 2010 Jan; 298(1):C163-70. PubMed ID: 19864325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
    Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
    FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
    Oyesanya RA; Lee ZP; Wu J; Chen J; Song Y; Mukherjee A; Dent P; Kordula T; Zhou H; Fang X
    FASEB J; 2008 Aug; 22(8):2639-51. PubMed ID: 18362203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
    Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
    Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
    Park KS; Kim MK; Im DS; Bae YS
    Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
    Boucharaba A; Serre CM; Guglielmi J; Bordet JC; Clézardin P; Peyruchaud O
    Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9643-8. PubMed ID: 16769891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
    Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
    Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
    Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS
    FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
    Mukherjee A; Wu J; Barbour S; Fang X
    J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid signaling in ovarian cancer.
    Jesionowska A; Cecerska-Heryc E; Matoszka N; Dolegowska B
    J Recept Signal Transduct Res; 2015; 35(6):578-84. PubMed ID: 26393967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts.
    Maeda-Sano K; Gotoh M; Morohoshi T; Someya T; Murofushi H; Murakami-Murofushi K
    Biochim Biophys Acta; 2014 Sep; 1841(9):1256-63. PubMed ID: 24845645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
    Hu YL; Albanese C; Pestell RG; Jaffe RB
    J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of growth-regulated oncogene alpha expression by estrogen in human endothelial cells.
    Lei ZB; Li XY; Wang BC; Yang YF; You NZ; Sun J
    Acta Pharmacol Sin; 2001 Nov; 22(11):1003-6. PubMed ID: 11749791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.